Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive Disorder
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
To compare the efficacy of escitalopram fixed dose 20 mg/day in combination with fixed doses
of gaboxadol (5 and 10 mg/day) versus escitalopram fixed dose 20 mg/day after 8 weeks of
treatment in patients with Major Depressive Disorder